health prnewswire_all 4/29/2026 14 views

NanoMosaic to Showcase the FDA/CBER AMT Designated Analytics Platform at ASGCT 2026

Beyond ddPCR for Gene Therapy: The Tessie™ system enables simultaneous capsid and transgene quantitation on a single chip in the same run, supporting accurate full, partial, and empty capsid characterization, potency assessment, and regulatory-relevant AAV quality control. BOSTON, April...
View original →